Section 3: Production and Compounding

3PC-034

DEVELOPMENT AND VALIDATION OF A METHOD FOR THE DETERMINATION OF VANCOMYCIN EYE DROPS BY ULTRAVIOLET-VISIBLE SPECTROPHOTOMETRY

3PC-031

PHYSICOCHEMICAL STABILITY OF helen.linxweiler@unimedizin-mainz.de DILUTED ‘THIOTEPA RIEMSER’ INFUSION SOLUTIONS IN PREFILLED 5% GLUCOSE INFUSION BAGS

3PC-013

PHARMACEUTICAL COMPOUNDING IN PAEDIATRIC PATCH TESTING: ARE WE SURE ABOUT THE ACTUAL ACTIVE INGREDIENT CONCENTRATION?

3PC-006

EVALUATION OF PARENTERAL NUTRITION COMPOUNDING THROUGH A CHECKLIST

3PC-016

VANCOMYCIN EYE DROPS AT 50 MG/ML : PHYSICOCHEMICAL STABILITY, IMPACT OF PACKAGING AND STORAGE CONDITIONS

3PC-014

EVALUATION OF THE MICROBIOLOGICAL QUALITY OF NONSTERILE DRUGS PREPARED IN A HOSPITAL PHARMACY

3PC-005

SELECTION OF AN OSMOLARITY VALIDATION MODEL FOR NOMINATIVE PARENTERAL NUTRITION

3PC-022

PH STABILITY OF TETRACAINE SOLUTIONS FOR SURFACE ANAESTHESIA

3PC-004

INSULIN EYE DROP FORMULATION: EFFECTIVENESS, SAFETY AND PATIENT SATISFACTION

3PC-002

GLASS AMPOULES AND DRUG FILTRATION: ¿HOW MUCH DO WE KNOW ABOUT IT?

3PC-020

CHEMICAL STABILITY AND PHYSICAL COMPATIBILITY OF INSULIN EYE DROPS USED IN CLINICAL PRACTICE

3PC-017

Assessing the stability of Sandoz rituximab biosimilar after exposure to out-of-fridge conditions for 21 days

3PC-009

STANOZOLOL RAPID HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) QUANTIFICATION METHOD FOR QUALITY CONTROL

3PC-035

Minimising Waste In Oncology

3PC-033

Y-site Compatibility of Intravenous Nefopam with Medications Commonly Used in Intensive Care Units

Pages